10 20 東京国際フォーラム OS - .10 50 50 20 15 00 e e e e e e e e e e e e e e e e e e e e page 1
10 20 東京国際フォーラム OS - .10 50 50 20 15 00 e e e e e e e e e e e e e e e e e e e e page 2
10 20 東京国際フォーラム OS - .10 50 50 20 15 00 e e e e e e e e e e e e e e e e e e e e page 3

10 20 東京国際フォーラム OS - .10 50 50 20 15 00 e e e e e e e e e e e e e e e e e e e e

  • View
    230

  • Download
    0

Embed Size (px)

Text of 10 20 東京国際フォーラム OS - .10 50 50 20 15 00 e e e e e e e e e e e e e e e e e e e e

  • 10

    50 50

    20

    15 00

    E E

    E

    E

    E

    EE

    E

    E

    E E

    E

    E

    E

    E

    E

    E

    E

    E

    E

    E

    E

    EL1-12

    EL1-13

    EL1-14

    EL1-16

    EL1-17

    EL1-18

    SEL1-19

    OS1-4CMDSBasic Science 1ChairHiromichi Matsushita

    OS1-7C

    OS1-7D

    OS1-8CAML

    OS1-8DAML

    OS1-9CCongenital AnemiaChairHiroshi Yagasaki

    OS1-9D 1

    OS1-10C

    OS1-10D 2

    17301830

    18301930

    OS1-12D

    OS1-13C

    OS1-13DInfection 1

    ChairNobu Akiyama

    ExcellentCase Report 2

    ExcellentCase Report 1

    OS1-14CMPN 1

    OS1-14DCML

    OS1-15D

    OS1-6C

    OS1-6D

    OS1-12C

    OS1-15CCAEBV/

    MTX

    OS1-11CMolecular Pathogenesis

    in MyelomaChairNaoya Mimura

    1-11DMultiple MyelomaMolecular TargetChairJiro Kikuchi

    OS1-4DMDS 1

    Special EducationalLecture SEL1-15ChairKiyohiko HataSpeakerSteven P. Treon

    OpeningCeremony

    Special LectureChairMasahiro KizakiSpeakerH. Phillip Koeffler

    IS1

    IS2

    IS3

    3

    Presidential SymposiumYoung Japanese hematologists in the world: Molecularpathogenesis of leukemia and leukemic stem cell (LSC)

    ChairsScott A. Armstrong, Stephen D. Nimer

    Part117301810Part217501830

    1-1 TR1-2 Pom/

    Dex 1-3 1-4

    1-5 ATL: 1-6 CLL 1-7 ALL: 11-8 CML: 11-9 CML: 21-10 KLd

    1-11

    1-12AML: 1-13AML: 11-14APL 1-151-161-171-181-191-20

    1-211-221-23 11-24 21-25 : 1-26 : 1-27MPN: 1-28MDS: 11-29MDS: 11-30MPN: 1-311-32 :

    11-331-341-351-36ITP1-371-381-39MCL 1-40 : CNS 1-411-42 : B 1-43B

    B2F E5FB5

    4FG4045FG504

    9001830

    B2F E7F

    11001730

    EL1-1

    EL1-5

    SEL1-9

    SEL1-10

    SEL1-11

    OS1-6BMyeloma Microenvironment

    ChairMasahiro Abe

    OS1-7AGenetic Analysis of AMLChairMasashi Sanada

    OS1-7BMolecular Target of AMLChairSusumu Goyama

    OS1-8AGVHD 1

    OS1-8BGVHD 2

    OS1-9A

    OS1-9B

    OS1-11A 1

    OS1-11B 2

    OS1-12A

    8001100

    OS1-12B 1

    OS1-13A

    OS1-13B

    OS1-14BALL 1

    OS1-6ANovel Therapy, MRD, andImmuno-Monitoring in MM

    ChairYoichi Imai

    OS1-10A

    OS1-10BMalignant LymphomaGenomic ResearchChairAkihiro Tomita

    EL1-2

    EL1-6

    EL1-3

    EL1-7

    Special EducationalLecture SEL1-4ChairMasafumi TaniwakiSpeakerShaji Kumar

    Special EducationalLecture SEL1-8ChairKensei TobinaiSpeakerSteven M. Horwitz

    EHA Special LectureChairYuzuru KanakuraSpeakerPieter Sonneveld

    LS1-2 /

    LS1-3CSL

    LS1-4

    LS1-13

    LS1-5

    LS1-6

    LS1-7

    LS1-9

    LS1-12

    LS1-8

    LS1-10MSD

    LS1-11

    LS1-14

    LS1-15

    Symposium 1Control of immune microenvironment in tumor

    ChairsYoshiki Akatsuka, Hiroshi Fujiwara

    Symposium 2Anemia and ineffective erythropoiesis

    ChairsHideo Harigae, Etsuro Ito

    9001830

    11001730

    E LIO

    SSS

    Industry Session

    10 4045 15 55 10 20 351400 1500 1600 1700 1800 1900 2000

    1400 1500 1600 1700 1800 1900 2000

    4F C

    27F B71

    37F B72

    45F B51

    55F B52

    67FD7

    75FD5

    81FD1

    94FG402

    04FG409

    15FG502

    25FG510

    36FG602

    46FG610

    57FG701

    6B2F 1

    7B2F 2

    E

    13001200110010 20

    1000900800

    1300120011001000900800

    1 10 20

  • 10 10

    50

    15 004500

    730

    EE

    E

    E

    E

    E

    E

    E

    E

    E

    E

    E

    E

    E E

    E

    E

    E

    E

    E

    EE

    E

    E

    17101810

    18101840

    ExcellentCase Report 4

    ExcellentCase Report 3

    Special EducationalLecture SEL2-12ChairMasao TomonagaSpeakerStephen D. Nimer

    Plenary SessionChairsItaru Matsumura, Takanori Teshima

    JSH-EHA Joint Symposium (Symposium 5)Novel treatment strategy for MM using novel drugs in

    combination with immune modulationChairsPieter Sonneveld, Shinsuke Iida

    Symposium 6New world of innate immunityNovel ontogeny and functions

    ChairsToshio Kitamura, Yoshio Katayama

    SHI (Socio-Hematology Issues) 2

    EL2-9

    EL2-13

    SEL2-17

    SEL2-18

    EL2-14

    EL2-15

    EL2-16

    SEL2-19

    EL2-10

    EL2-11

    Special EducationalLecture SEL1-15ChairKiyohiko HataSpeakerSteven P. Treon

    EL1-16

    EL1-17

    EL1-18

    EL1-12

    EL1-13

    EL1-14

    SEL1-19

    OS2-11D T 1

    1845 20303F

    E

    E

    Scientific Exchange TrainingProgramSETP730 830

    SETP1"Lymphoma"CommentatorWyndham WilsonModeratorKoji Izutsu

    SETP2"Myelodysplastic Syndromes"CommentatorRafael BejarModeratorHironori Harada

    OS2-6CAML

    OS2-6DAML

    OS2-9CMPNBasic Science 1

    ChairOsamu Miura

    OS2-9DMPN 2

    OS2-10CCML 1

    OS2-10DCMLBasic Science 2ChairTetsuzo Tauchi

    OS2-8CALL 2

    OS2-8DALL

    OS2-11C

    OS2-12CDIC/TMA

    OS2-12DThromboisis and HemostasisChairTadashi Matsushita

    OS2-13C

    OS2-13D

    OS2-14C 1

    OS2-14D 2

    OS2-15CDLBCL 1

    OS2-15DDLBCL 2

    E

    E

    E

    E

    2-1 Malignant Lymphoma: ClinicalResearch

    2-2 : B2-3 NKTL 2-4 2-5

    2-6 Ph+ALL2-7 ALL: 22-8 CML: 12-9 CML: 22-10HDAC

    2-11 ELd 2-12AML: 2-13AML: 22-14AML 2-152-16MDS: 22-17MDS: 22-182-192-20 Allogeneic SCT2-21GVHD2-22 12-23 2

    B2F E5FB5

    4FG4045FG504

    9001830

    B2F E7F

    11001710

    Part117101750Part217301810

    2-242-25 : 2-26 T : 2-272-28 Pediatric Hematology 12-29 22-30 :

    2-31 : T

    EB2-322-33 2-342-352-362-37DIC/TMA2-38 Retrospective Analysis on

    Treatment Outcome of MM2-39 :

    22-40PTCL2-41 : 12-42 : 2-43 : 22-44 :

    8001100

    ASH Special LectureChairKinuko MitaniSpeakerKenneth C. Anderson

    LS2-2

    MS2-2

    LS2-3

    MS2-3

    LS2-4

    MS2-4

    LS2-5

    MS2-5

    LS2-6

    MS2-6

    LS2-7

    MS2-7MSD

    LS2-8

    LS2-9

    MS2-9

    LS2-10

    MS2-10

    LS2-11

    MS2-11

    LS2-12

    MS2-12

    LS2-13

    MS2-13

    LS2-14

    MS2-14

    LS2-15Meiji Seika

    Symposium 4Cutting-edge of basic and clinical research for

    malignant lymphomaChairsKunihiro Tsukasaki, Hirokazu Nagai

    SHI (Socio-Hematology Issues) 1

    Asian Joint Panel DiscussionMDS/MPNProgress of basic and clinical research in Asia

    ChairsHyeoung-Joon Kim, Norio Komatsu

    EL2-1

    EL2-2

    EL2-3

    SEL2-4

    EL2-5

    EL2-6

    EL2-7

    SEL2-8

    Special EducationalLecture SEL1-4ChairMasafumi TaniwakiSpeakerShaji Kumar

    Special EducationalLecture SEL1-8ChairKensei TobinaiSpeakerSteven M. Horwitz

    EL1-1

    EL1-5

    EL1-6

    EL1-7

    SEL1-9

    SEL1-10

    SEL1-11

    EL1-2

    EL1-3

    OS2-9A

    OS2-10B

    OS2-4A

    OS2-6AALLCLL

    OS2-6BPh+ALL

    OS2-9B

    OS2-10A

    OS2-11A

    OS2-11B

    OS2-12APediatric Hematology 1ChairTakeshi Taketani

    OS2-12BPediatric Hematology 2ChairMasahiro Hirayama

    OS2-13AGVHD 3

    OS2-13B

    OS2-14A

    OS2-14B

    OS2-8AMDS 2

    OS2-8BMDS 3

    OS2-4B

    9001830

    11001710

    SETP1"Lymphoma"

    SETP2"MyelodysplasticSyndromes"

    E

    SSS

    LMO

    40 50101400 1500 1600 1700 1800 1900 2000

    1400 1500 1600 1700 1800 1900 2000

    4F C

    27F B71

    37F B72

    45F B51

    55F B52

    67FD7

    75FD5

    81FD1

    94FG402

    04FG409

    15FG502

    25FG510

    36FG602

    46FG610

    57FG701

    6B2F 1

    7B2F 2

    E

    20101300120011001000900800

    1300120011001000900800

    2 10 21

  • 20

    1025

    730

    4500

    E

    E

    E

    E

    E E

    E

    EE

    E

    EE

    E

    E EE

    E

    E

    E

    E

    EE

    EE

    E E

    E

    E

    E

    SEL2-4

    EL2-13

    EL2-14

    EL2-15

    EL2-16

    EL2-1

    EL2-2

    EL2-3

    OS3-4D

    OS3-9D

    OS3-9C

    OS3-8C

    OS3-10DCLL

    ChairYukio Kobayashi

    OS3-10CALLBasic Research 3ChairToshihiko Imamura

    OS3-11DCNS

    OS3-11C

    OS3-13DATL 2

    OS3-13CATL 1

    OS3-14D

    OS3-14C 2

    OS3-12CTreatment for Refractory Multiple Myeloma 1Daratumumab (POLLUX) ,Elotuzumab etc.

    ChairShigeki Ito

    OS3-12DTreatment for Refractory Multiple Myeloma 2

    Daratumumab (CASTOR) ,etc.ChairTadao Ishida

    OS3-15CMolecular Mechanismof Leukemogenesis 1ChairYasuhiko Kamikubo

    OS3-15DMolecular Mechanismof Leukemogenesis 2ChairToshiya Inaba

    OS3-8D

    EL3-8

    EL3-9

    EL3-12

    SEL3-16

    EL3-13

    EL3-14

    EL3-15

    EL3-10

    SEL3-11

    Symposium 10GVHD A bench-to-bedside update

    ChairsMakoto Murata, Junya Kanda

    SHI (Socio-Hematology Issues) 4

    SHI (Socio-Hematology Issues) 1

    Symposium 9Myeloid neoplasia and clinical sequence

    ChairsSeishi Ogawa, Yasushi Miyazaki

    E

    E

    Scientific Exchange TrainingProgramSETP730 830

    SETP3"Multiple Myeloma"CommentatorKenneth C. Anderson,ModeratorJunya Kuroda

    SETP4"Acute Myeloid Leukemia/LeukemicStem Cell"CommentatorScott A. ArmstrongModeratorYoichi Imai

    9001530

    8001530

    Closing

    Ceremony

    Special EducationalLecture SEL2-12ChairMasao TomonagaSpeakerStephen D. Nimer

    MS3-2

    LS3-2

    MS3-3

    LS3-3

    MS3-4

    LS3-4

    MS3-5

    LS3-5

    MS3-6

    LS3-6

    MS3-7

    LS3-7

    LS3-8

    MS3-9

    LS3-9

    MS3-10

    LS3-10

    MS3-11

    LS3-11

    MS3-12

    LS3-12

    MS3-13CSL

    LS3-13

    LS3-14JCR

    LS3-15